Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2Other hematologic neoplasm 2Thoracic 1Other solid neoplasm 1Gastrointestinal 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1

Interventions

Cytarabine 465Cyclophosphamide 459fludarabine phosphate 277Rituximab 249Methotrexate 245Etoposide 203fludarabine 200Filgrastim 199Peripheral Blood Stem Cell Transplantation 180Busulfan 169Vincristine 163Dexamethasone 153Daunorubicin 151Azacitidine 145Mycophenolic Acid 142Whole-Body Irradiation 133Tacrolimus 127Imatinib Mesylate 127Cyclosporine 123Granulocyte Colony-Stimulating Factor 118Radiotherapy 113Melphalan 110Idarubicin 103Doxorubicin 101Mitoxantrone 97Decitabine 97Antilymphocyte Serum 97Lenalidomide 96Mercaptopurine 93Prednisone 91

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Fecal Microbiota Transplantation × Other hematologic neoplasm × Clear all
NCT03678493 2024-05-16

A Study of FMT in Patients With AML Allo HSCT in Recipients

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
100 enrolled 19 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03812705 2024-04-23

FEMITGIGVHD

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Completed
6 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡